Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis

References

• Johns Hopkins Coronavirus Resource Center. COVID-19 Map Baltimore: Johns Hopkins University; 2020 [cited 2021 Jun 4]. Available from: coronavirus.jhu.edu
   Google Scholar
• Institute for Health Metrics & Evaluation (IHME). COVID-19 Projects assuming full social distancing through May 2020: Total Deaths Seattle: University of Washington; 2020 [cited 2021 Jan 13]. Available from: www.healthdata.org.
   Google Scholar
• Yancy CW. COVID-19 and African Americans. JAMA. 2020;323(19):1891–1892.
   PubMed Web of Science ®Google Scholar
• Mehta HB, Ehrhardt S, Moore TJ, et al. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis. BMJ Open. 2020;10(6):e039978.
   PubMed Web of Science ®Google Scholar
• Sanders JM, Monogue ML, Jodlowski TZ, et al. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;323(18):1824–1836.
   PubMed Web of Science ®Google Scholar
• Park A. COVID-19 vaccine shipped, and drug trials start time. New York: TIME, 2020.
   Google Scholar
• Mauskopf J, Standaert B, Connolly MP, et al. Economic analysis of vaccination programs: an ISPOR good practices for outcomes research task force report. Value Health. 2018;21(10):1133–1149.
   PubMed Web of Science ®Google Scholar
• Carvalho N, Jit M, Cox S, et al. Capturing budget impact considerations within economic evaluations: a systematic review of economic evaluations of rotavirus vaccine in low- and middle-income countries and a proposed assessment framework. PharmacoEconomics. 2018;36(1):79–90.
   PubMed Web of Science ®Google Scholar
• Apuzzo M, Kirkpatrick DD. COVID-19 changed how the world does science, together. New York Times. 2020 Apr 1.
   Google Scholar
• Whittington MD. Campbell JD, Institute for Clinical and Economic Review (ICER). Alternative Pricing Models for Remdesivire and Other Potential Treatments fo COVID-19 Cambridge, MA: Institute for Clinical and Economic Review (ICER); 2020 [cited 2020 Jun 12]. Available from: https://icer-review.org/wp-content/uploads/2020/05/ICER-COVID_Initial_Abstract_05012020-3.pdf.
   Google Scholar
• Bordi L, Nicastri E, Scorzolini L, et al. Eleonara L; INMI COVID-10 study group and collaborating centers. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Euro Surveillance. 2020;25(8):2000170.
   Google Scholar
• Iwata K, Miyakoshi C. A simulation on potential secondary spread of novel coronavirus in an exported country using a stochastic epidemic SEIR model. J Clin Med. 2020;9(4):944.
   Web of Science ®Google Scholar
• Wei YY, Lu ZZ, Du ZC, et al. Fitting and forecasting the trend of COVID-19 by SEIR(+CAQ) dynamic model. Zhonghua Liu Xing Bing Xue za Zhi = Zhonghua Liuxingbingxue Zazhi. 2020;41(4):470–475.
   PubMedGoogle Scholar
• Hou C, Chen J, Zhou Y, et al. The effectiveness of quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): a well-mixed SEIR model analysis . J Med Virol. 2020;92(7):841–848.
   PubMed Web of Science ®Google Scholar
• Gu Y. COVID-19 projections using machine learning 2020 [cited 2020 Aug 10]. Available from: https://covid19-projections.com/.
   Google Scholar
• Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093–1103.
   PubMed Web of Science ®Google Scholar
• Phelps CE. A new method to determine the optimal willingness to pay in cost-effectiveness analysis. Value Health. 2019;22(7):785–791.
   PubMed Web of Science ®Google Scholar
• Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing Copyright © 2020, StatPearls Publishing LLC; 2020.
   Google Scholar
• Shi Y, Wang Y, Shao C, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27(5):1451–1454.
   PubMed Web of Science ®Google Scholar
• Fine P, Eames K, Heymann DL. “Herd immunity”: a rough guide. Clin Infect Dis. 2011;52(7):911–916.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zeng Z, Wang K, et al. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac Dis. 2020;12(3):165–174.
   PubMed Web of Science ®Google Scholar
• Eames KT, Tilston NL, Brooks Pollock E, et al. Measured dynamic social contact patterns explain the spread of H1N1v influenza. PLOS Comput Biol. 2012;8(3):e1002425.
   PubMed Web of Science ®Google Scholar
• Whitehead S. CDC director on models for the months to come: “this virus is going to be with us”. Washington (DC): National Public Radio; 2020 [cited 2020 Apr 8]. Available from: https://www.npr.org/sections/health-shots/2020/03/31/824155179/cdc-director-on-models-for-the-months-to-come-this-virus-is-going-to-be-with-us
   Google Scholar
• Chinese Center For Disease Control Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(2):145–151.
   PubMedGoogle Scholar
• Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:343–346.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Key Updates for Week 45, ending November 7, 2020. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/pdf/covidview-11-13-2020.pdf
   Google Scholar
• GAVI the Vaccine Alliance. What is Herd Immunity?: GAVI; 26 March 2020 [cited 2020 Apr 8]. Available from: https://www.gavi.org/vaccineswork/what-herd-immunity
   Google Scholar
• Bureau of Labor Statistics. Technical Information about the BLS Major Sector Productivity and Costs Measure Washington, D.C.: U.S. Bureau of Labor Statistics; 2008 [cited 2020 Apr 8]. Available from: https://www.bls.gov/lpc/lpcmethods.pdf
   Google Scholar
• Drugs.com. Acetaminophen Prices, Coupons and Patient Assistance Programs 2020 [cited 2020 Apr 8]. Available from: https://www.drugs.com/price-guide/acetaminophen#oral-tablet-325-mg
   Google Scholar
• Drugs.com. Tussin EXPECTORANT 2020 [cited 2020 Apr 20]. Available from: https://www.drugs.com/otc/102841/tussin-expectorant.html
   Google Scholar
• Drugs.com. Benzonatate Prices, Coupons and Patient Assistance Programs 2020 [cited 2020 Apr 8]. Available from: https://www.drugs.com/price-guide/benzonatate
   Google Scholar
• Castlight Health. The Costs of COVID-19 2020 [cited 2020 Apr 8]. Available from: https://www.castlighthealth.com/wp-content/uploads/2020/03/Costs-of-COVID-19.pdf
   Google Scholar
• Rae MC, Kurani N, McDermott D, et al. Potential Costs of Coronavirus Treatment for People with Employer Coverage: Peterson-KFF; 2020 [cited 2020 Apr 8]. Available from: https://www.healthsystemtracker.org/brief/potential-costs-of-coronavirus-treatment-for-people-with-employer-coverage/
   Google Scholar
• World Health Organization. WHO Guideline on Country Pharmaceutical Pricing Policies Geneva: World Health Organization; 2015 [cited 2020 Apr 8]. Available from: https://apps.who.int/iris/bitstream/handle/10665/153920/9789241549035_eng.pdf
   Google Scholar
• Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26(4):410–420.
   PubMed Web of Science ®Google Scholar
• Khan K, Muennig P, Gardam M, et al. Managing febrile respiratory illnesses during a hypothetical SARS outbreak. Emerg Infect Dis. 2005;11(2):191–200.
   PubMed Web of Science ®Google Scholar
• Lee BY, Bartsch SM, Brown ST, et al. Quantifying the economic value and quality of life impact of earlier influenza vaccination. Med Care. 2015;53(3):218–229.
   PubMed Web of Science ®Google Scholar
• Pike J, Grosse SD. Friction cost estimates of productivity costs in cost-of-illness studies in comparison with human capital estimates: a review. Appl Health Econ Health Policy. 2018;16(6):765–778.
   PubMed Web of Science ®Google Scholar
• Molinari NAM, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–5096.
   PubMed Web of Science ®Google Scholar
• Swift A. Most US employed adults plan to work past retirement age. Washington (DC): Gallup; 2017.
   Google Scholar
• Padula WV, Connor KA, Mueller JM, et al. Cost benefit of comprehensive primary and preventive school-based health care. Am J Prev Med. 2018;54(1):80–86.
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43(7):736–749.
   PubMed Web of Science ®Google Scholar
• Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43(3):203–220.
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Schillie S, Wittenborn JS, et al. Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes. Diabetes Care. 2013;36(1):63–69.
   PubMed Web of Science ®Google Scholar
• Briggs AH. Handling uncertainty in cost-effectiveness models. PharmacoEconomics. 2000;17(5):479–500.
   PubMed Web of Science ®Google Scholar
• Briggs AH, Goeree R, Blackhouse G, et al. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making. 2002;22(4):290–308.
   PubMed Web of Science ®Google Scholar
• Pandya A. Adding cost-effectiveness to define low-value care. JAMA. 2018;319(19):1977–1978.
   PubMed Web of Science ®Google Scholar
• Sharma M, Ortendahl J, van der Ham E, et al. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand. BJOG. 2012;119(2):166–176.
   PubMed Web of Science ®Google Scholar
• 116th Congress. Coronavirus aid, relief and economic security (CARES) act. Washington, D.C.; 2020.
   Google Scholar
• Boccia R, Burke L, Burton D, et al. Congress should focus on pandemic control and fix the CARES act for an economic rebound. Washington: The Heritage Foundation; 2020.
   Google Scholar
• Canady VA. CARES act to help providers bolster care; supports communities, businesses. Mental Health Weekly. 2020;30(14):1–3.
   Google Scholar
• Cicchetti A, Ruggeri M, Gitto L, et al. Extending influenza vaccination to individuals aged 50–64: a budget impact analysis. Int J Technol Assess Health Care. 2010;26(3):288–293.
   PubMed Web of Science ®Google Scholar
• Sloan FA, Becker ER. Cross-subsidies and payment for hospital care. J Health Polit Policy Law. 1984;8(4):660–685.
   PubMed Web of Science ®Google Scholar
• Engelhardt GV, Gruber J. Medicare part D and the financial protection of the elderly. J Am Econ J: Econ Policy. 2011;3(4):77–102.
   Web of Science ®Google Scholar
• Hurley LP, Lindley MC, Harpaz R, et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010;152(9):555–560.
   PubMed Web of Science ®Google Scholar
• Brennan H, Kapczynski A, Monahan CH, et al. A prescription for excessive drug pricing: leveraging government patent use for health. Yale J Law Technology. 2016;18(1):275–354.
   Google Scholar
• Sharfstein JM, Lee J, Conti RM. We have a cure for hepatitis C. But the neediest can’t afford it. Louisiana wants to change that. Washington (DC):Vox; 2017.
   Google Scholar
• James SF, Chahine EB, Sucher AJ, et al. Shingrix: the new adjuvanted recombinant herpes zoster vaccine. Ann Pharmacother. 2018;52(7):673–680.
   PubMed Web of Science ®Google Scholar
• Eligon J, Burch ADS, Searcey D Jr, et al. Black Americans Face Alarming Rates of Coronavirus Infection in Some States. The New York Times. 2020 Apr 8.
   Google Scholar